Proto Labs Inc (PRLB) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 42.36M USD | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 14.79M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 36.81M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $42.36M | (m) | $14.79M | $36.81M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $42.74M | (m) | $14.96M | $30.42M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $42.81M | (m) | $15.73M | $25.11M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $42.19M | (m) | $16.21M | $16.82M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $41.25M | (m) | $16.73M | $16.59M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $40.74M | (m) | $16.71M | $17.61M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $41.30M | (m) | $17.00M | $19.91M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $41.09M | (m) | $16.89M | $29.80M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $41.42M | (m) | $17.14M | $31.64M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $40.63M | (m) | $16.57M | $31.25M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $40.13M | (m) | $15.99M | $28.17M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $39.55M | (m) | $16.02M | $-97.36M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $38.76M | (m) | $16.49M | $-101.72M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $38.34M | (m) | $16.84M | $-102.12M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $38.22M | (m) | $17.55M | $-97.98M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $39.70M | (m) | $16.89M | $32.20M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $41.01M | (m) | $16.96M | $33.07M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $42.62M | (m) | $17.87M | $43.97M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $44.24M | (m) | $19.09M | $40.34M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $45.24M | (m) | $19.59M | $38.28M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $42.55M | (m) | $18.56M | $49.02M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $40.13M | (m) | $17.26M | $47.27M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $36.94M | (m) | $14.67M | $59.84M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $33.70M | (m) | $11.66M | $68.41M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $34.15M | (m) | $10.93M | $72.01M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $33.67M | (m) | $10.77M | $77.23M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $32.69M | (m) | $10.78M | $79.86M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $32.12M | (m) | $12.68M | $80.45M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $31.22M | (m) | $12.42M | $84.21M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $30.08M | (m) | $11.66M | $86.62M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $28.73M | (m) | $10.93M | $88.90M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $26.93M | (m) | $10.38M | $87.52M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $25.35M | (m) | $9.63M | $81.85M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $24.40M | (m) | $9.15M | $76.27M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $23.56M | $344.49M | $8.56M | $72.23M | (m) | 6.84% | 2.48% | (m) | (m) |
| 2017-09-30 | $23.06M | $322.67M | $7.67M | $68.28M | (m) | 7.15% | 2.38% | (m) | (m) |
| 2017-06-30 | $23.16M | $312.73M | $7.19M | $65.86M | (m) | 7.41% | 2.30% | (m) | (m) |
| 2017-03-31 | $22.89M | $305.65M | $6.76M | $64.31M | (m) | 7.49% | 2.21% | (m) | (m) |
| 2016-12-31 | $22.39M | $298.06M | $6.78M | $61.77M | (m) | 7.51% | 2.27% | (m) | (m) |
| 2016-09-30 | $21.99M | $299.46M | $6.83M | $63.49M | (m) | 7.34% | 2.28% | (m) | (m) |
| 2016-06-30 | $20.77M | $289.13M | $6.71M | $63.95M | (m) | 7.18% | 2.32% | (m) | (m) |
| 2016-03-31 | $19.35M | $278.14M | $6.47M | $66.45M | (m) | 6.96% | 2.33% | (m) | (m) |
| 2015-12-31 | $18.35M | $264.11M | $6.08M | $67.15M | (m) | 6.95% | 2.30% | (m) | (m) |
| 2015-09-30 | $18.15M | $246.42M | $5.76M | $65.25M | (m) | 7.37% | 2.34% | (m) | (m) |
| 2015-06-30 | $17.95M | $233.15M | $5.47M | $63.29M | (m) | 7.70% | 2.35% | (m) | (m) |
| 2015-03-31 | $17.46M | $222.04M | $5.15M | $61.92M | (m) | 7.87% | 2.32% | (m) | (m) |
| 2014-12-31 | $16.61M | $209.58M | $4.81M | $60.53M | (m) | 7.92% | 2.29% | (m) | (m) |
| 2014-09-30 | $15.38M | $197.56M | $4.43M | $59.74M | (m) | 7.79% | 2.24% | (m) | (m) |
| 2014-06-30 | $13.85M | $184.99M | $3.97M | $57.70M | (m) | 7.49% | 2.15% | (m) | (m) |
| 2014-03-31 | $12.69M | $171.87M | $3.59M | $54.35M | (m) | 7.38% | 2.09% | (m) | (m) |
| 2013-12-31 | $11.86M | $163.11M | $3.46M | $51.30M | (m) | 7.27% | 2.12% | (m) | (m) |
| 2013-09-30 | $10.92M | $152.69M | $3.27M | $47.69M | (m) | 7.15% | 2.14% | (m) | (m) |
| 2013-06-30 | $10.46M | $143.13M | $3.15M | $43.87M | (m) | 7.30% | 2.20% | (m) | (m) |
| 2013-03-31 | $10.11M | $133.33M | $3.05M | $38.70M | (m) | 7.58% | 2.29% | (m) | (m) |
| 2012-12-31 | $9.14M | $125.99M | $3.04M | $34.95M | (m) | 7.25% | 2.41% | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $5.22M | $98.94M | $1.13M | $26.87M | (m) | 5.28% | 1.14% | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $4.28M | $64.92M | $331.00K | $15.93M | (m) | 6.59% | 0.51% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INNOVATE Corp. (VATE) | United States | $0.102B | |
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |
| Arcosa, Inc. (ACA) | United States | $7.195B | 14.51 |
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |